SLC22A3 ELISA Kit

Produktnummer ABIN6227163

Produktdetails SLC22A3 ELISA Kit

Target: SLC22A3 (OCT3) (Organic Cation Transporter 3 (OCT3))

Reaktivität: Ratte

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.156 ng/mL - 10 ng/mL

Untere Nachweisgrenze: 0.156 ng/mL

Applikation: ELISA

Verwendungszweck: Rat Slc22a3 ELISA Kit is an ELISA Kit against Slc22a3.

Proben: Plasma, Serum

Analytische Methode: Quantitative

Sensitivität: < 0.094 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Referenzen für SLC22A3 ELISA Kit (ABIN6227163)

Zapała, Niemczyk, Zapała, Wdowiak, Bojar, Kluz, Szopa, Serefko, Radziszewski, Wróbel: "The Cannabinoid Ligand Arachidonyl-2'-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model." in: International journal of molecular sciences, Vol. 24, Issue 4, (2023) (PubMed).

Juszczak, Adamowicz, Zapała, Kluz, Adamczyk, Wdowiak, Bojar, Misiek, Grzybowska, Stangel-Wójcikiewicz, Poleszak, Pokrywczyńska, Drewa, Wróbel: "Potentilla chinensis aqueous extract attenuates cyclophosphamide-induced hemorrhagic cystitis in rat model." in: Scientific reports, Vol. 12, Issue 1, pp. 13076, (2022) (PubMed).

Zapała, Juszczak, Adamczyk, Adamowicz, Ślusarczyk, Kluz, Misiek, Rogowski, Grzybowska, Stangel-Wójcikiewicz, Zaborowski, Poleszak, Radziszewski, Wróbel: "New Kid on the Block: The Efficacy of Phytomedicine Extracts Urox® in Reducing Overactive Bladder Symptoms in Rats." in: Frontiers in molecular biosciences, Vol. 9, pp. 896624, (2022) (PubMed).

Wróbel, Zapała, Kluz, Rogowski, Misiek, Juszczak, Sieńko, Gold, Stangel-Wójcikiewicz, Poleszak, Radziszewski: "The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats." in: International journal of molecular sciences, Vol. 22, Issue 11, (2021) (PubMed).

Wróbel, Serefko, Szopa, Poleszak: "Stimulation of atypical cannabinoid receptor GPR55 abolishes the symptoms of detrusor overactivity in spontaneously hypertensive rats." in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 150, pp. 105329, (2020) (PubMed).

Wróbel, Serefko, Szopa, Poleszak: "Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity." in: Frontiers in pharmacology, Vol. 11, pp. 574108, (2020) (PubMed).

Wróbel, Serefko, Szopa, Ulrich, Poleszak, Rechberger: "O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment." in: Frontiers in pharmacology, Vol. 11, pp. 1002, (2020) (PubMed).

Wróbel, Szopa, Serefko, Poleszak: "A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors." in: Molecules (Basel, Switzerland), Vol. 25, Issue 6, (2020) (PubMed).

Details zu SLC22A3

Target: SLC22A3 (OCT3) (Organic Cation Transporter 3 (OCT3))

Andere Bezeichnung: SLC22A3 (OCT3 Produkte)

UniProt: O88446